On November 25, 2025, we posted a blog regarding the issuance of the first Generic Drugs Program Monthly and Quarterly Activities Report for FY 2026. It contained information on the number of ANDA receipts in October 2025, and that number, as reported in the monthly report, was 1. We posited four potential reasons why that occurred because, [...]The post Why Was Only One ANDA Application Submitted in October 2025? Find the Answer Here! appeared first on Lachman Consultant Services, Inc..